ATLANTA, April 05, 2016 -- Manhattan Associates, Inc. (NASDAQ:MANH) today announced its latest Slotting Optimization offering at MODEX 2016 in Atlanta. Featuring an enhanced, state-of-the-art algorithm; mobile capabilities; and a common data model with Warehouse Management, Manhattan’s Slotting Optimization delivers market-leading capabilities to address the increasing demands of today’s e-commerce distribution centers.
“Traditional slotting optimization tools must now be faster, easier to use and fully integrated with broader warehouse management solutions to support today’s expanding omni-channel environment,” said Peter Schnorbach, senior director of product management, Manhattan Associates. “Manhattan Associates understands the challenges of 21st century omni-channel retail and is dedicated to advancing our solutions to address our customers’ changing needs. Our latest release revolutionizes the slotting process with the most streamlined and versatile features available on the market today.”
Slotting requirements have changed dramatically over the past five years. While warehouses were previously re-optimized based on seasonality or periodic inventory resets, today’s e-commerce brands introduce and promote new products on a near constant basis. As a result, warehouse inventory is changing much more regularly, and slotting schedules have increased dramatically. This has put significant strain on warehouse processes.
Manhattan’s Slotting Optimization release addresses these challenges with a modern, enhanced algorithm based on the latest optimization and mathematical concepts and designed to deliver speed and ease of use. This new solution integrates seamlessly with Manhattan’s Distribution Management (DM) Mobile application. This allows warehouse managers to execute re-slotting requests directly from the warehouse floor with just the click of a button, versus returning to their desks and running requests through a stationary system.
Manhattan Associates representatives will be at booth 1939 throughout MODEX 2016, where they will offer demos of Slotting Optimization and the company’s broader distribution management solutions.
Receive up-to-date product, customer and partner news directly from Manhattan Associates on Twitter and Facebook.
About Manhattan Associates
Manhattan Associates makes commerce-ready supply chains that bring all points of commerce together so you’re ready to sell and ready to execute. Across the store, through your network or from your fulfillment center, we design, build and deliver market-leading solutions that support both top-line growth and bottom-line profitability. By converging front-end sales with back-end supply chain execution, our software, platform technology and unmatched experience help our customers get commerce ready—and ready to reap the rewards of the omni-channel marketplace. For more information, please visit www.manh.com.
Press Contact: Amber Freeman Manhattan Associates 678-597-6820 [email protected]


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



